Astana Biomed Group, an authorized Abcam distributor in Central Asia

Anti-LIPH antibody [EP12065] - BSA and Azide free (ab251146)

Key features and details

  • Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
  • Rabbit monoclonal [EP12065] to LIPH - BSA and Azide free
  • Suitable for: WB, IHC-P
  • Reacts with: Human

Overview

  • Product name

    Anti-LIPH antibody [EP12065] - BSA and Azide free
    See all LIPH primary antibodies

  • Description

    Rabbit monoclonal [EP12065] to LIPH - BSA and Azide free

  • Host species

    Rabbit

  • Tested Applications & Species

    Application Species
    IHC-P
    Human
    WB
    Human
    See all applications and species data

  • Immunogen

    Synthetic peptide. This information is proprietary to Abcam and/or its suppliers.

  • General notes

    Ab251146 is the carrier-free version of ab192615. This format is designed for use in antibody labeling, including fluorochromes, metal isotopes, oligonucleotides, enzymes.

     

    Our carrier-free formats are supplied in a buffer free of BSA, sodium azide and glycerol for higher conjugation efficiency.

    Use our conjugation kits  for antibody conjugates that are ready-to-use in as little as 20 minutes with

    ab251146 is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm.

    Maxpar® is a trademark of Fluidigm Canada Inc.

    This product is a recombinant monoclonal antibody, which offers several advantages including:

    • - High batch-to-batch consistency and reproducibility
    • - Improved sensitivity and specificity
    • - Long-term security of supply
    • - Animal-free production
    For more information see here.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

Properties

Images

  • Western blot - Anti-LIPH antibody [EP12065] - BSA and Azide free (ab251146)
    Western blot - Anti-LIPH antibody [EP12065] - BSA and Azide free (ab251146)
    Anti-LIPH antibody [EP12065] (ab192615) at 1/20000 dilution + Human prostate cancer tissue lysate at 10 µg

    Secondary
    Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution

    Predicted band size: 51 kDa



    This data was developed using ab192615, the same antibody clone in a different buffer formulation.

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LIPH antibody [EP12065] - BSA and Azide free (ab251146)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LIPH antibody [EP12065] - BSA and Azide free (ab251146)
    This data was developed using ab192615, the same antibody clone in a different buffer formulation.Immunohistochemical analysis of paraffin-embedded Human glioma tissue labeling LIPH with ab192615 at 1/1000 dilution (1μg/ml). A Ready to use HRP Polymer for Rabbit IgG (prediluted) was used as secondary. Counterstain: Hematoxylin. Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
  • Western blot - Anti-LIPH antibody [EP12065] - BSA and Azide free (ab251146)
    Western blot - Anti-LIPH antibody [EP12065] - BSA and Azide free (ab251146)
    All lanes : Anti-LIPH antibody [EP12065] (ab192615) at 1/5000 dilution

    Lane 1 : Human pancreas tissue lysate
    Lane 2 : Human prostate cancer tissue lysate

    Lysates/proteins at 20 µg per lane.

    Secondary
    All lanes : Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution

    Predicted band size: 51 kDa



    This data was developed using ab192615, the same antibody clone in a different buffer formulation.

     

  • Anti-LIPH antibody [EP12065] - BSA and Azide free (ab251146)
    Anti-LIPH antibody [EP12065] - BSA and Azide free (ab251146)

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

© 2021 Astana Biomed Group LLP. All rights reserved.